# Evaluation of LB in THA

> **NCT03341104** · — · COMPLETED · sponsor: **OSF Healthcare System** · enrollment: 173 (actual)

## Conditions studied

- Hip Disease

## Interventions

- **DRUG:** Bupivacaine liposome

## Key facts

- **NCT ID:** NCT03341104
- **Lead sponsor:** OSF Healthcare System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-01
- **Primary completion:** 2016-07-30
- **Final completion:** 2016-07-30
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2017-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03341104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03341104, "Evaluation of LB in THA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03341104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*